Author:
Kintz Pascal,Gheddar Laurie,Garnier Delphine
Reference31 articles.
1. Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial
2. Liver injury after selective androgen receptor modulator intake: a case report and review of the literature;Mertens;Gastroenterol.,2023
3. Peroxisome proliferator-activated receptor delta agonist (PPAR-) and selective androgen receptor modulator (SARM) abuse: clinical, analytical and biological data in a case involving a poisonous combination of GW1516 (cardarine) and MK2866 (ostarine);Kintz;Toxics,2021
4. Dietary supplements: a gateway to doping?;Mallick;Nutrients,2023
5. Analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders;Fabresse;Forensic Sci. Int.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献